Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Outcomes of transcatheter aortic valve implantations in high-volume or low-volume centres in Germany.

Oettinger V, Kaier K, Heidt T, Hortmann M, Wolf D, Zirlik A, Zehender M, Bode C, von Zur Mühlen C, Stachon P.

Heart. 2020 Feb 18. pii: heartjnl-2019-316058. doi: 10.1136/heartjnl-2019-316058. [Epub ahead of print]

PMID:
32071092
2.

A logistic regression analysis comparing minimalistic approach and intubation anaesthesia in patients undergoing transfemoral transcatheter aortic valve replacement.

Maier A, Hammerich B, Humburger F, Brieschal T, Heidt T, Bothe W, Schröfel H, Kaier K, Zehender M, Reinöhl J, Bode C, von Zur Mühlen C, Stachon P.

PLoS One. 2020 Feb 5;15(2):e0227345. doi: 10.1371/journal.pone.0227345. eCollection 2020.

3.

[Coronary physiology in the catheter laboratory].

Baumann S, Bojara W, Post H, Rudolph T, Schäufele T, Ong P, Lehmann R, von Zur Mühlen C.

Herz. 2020 Jan 14. doi: 10.1007/s00059-019-04878-y. [Epub ahead of print] Review. German.

PMID:
31938804
4.

Dysregulation of the Mitochondrial Proteome Occurs in Mice Lacking Adiponectin Receptor 1.

Pepin ME, Koentges C, Pfeil K, Gollmer J, Kersting S, Wiese S, Hoffmann MM, Odening KE, von Zur Mühlen C, Diehl P, Stachon P, Wolf D, Wende AR, Bode C, Zirlik A, Bugger H.

Front Endocrinol (Lausanne). 2019 Dec 13;10:872. doi: 10.3389/fendo.2019.00872. eCollection 2019.

5.

Publisher Correction: Real-time magnetic resonance imaging - guided coronary intervention in a porcine model.

Heidt T, Reiss S, Krafft AJ, Özen AC, Lottner T, Hehrlein C, Galmbacher R, Kayser G, Hilgendorf I, Stachon P, Wolf D, Zirlik A, Düring K, Zehender M, Meckel S, von Elverfeldt D, Bode C, Bock M, von Zur Mühlen C.

Sci Rep. 2019 Nov 29;9(1):18282. doi: 10.1038/s41598-019-54947-9.

6.

Modeling the Volume-Outcome Relationship for TAVR.

Kaier K, Bode C, Zehender M, von Zur Mühlen C, Stachon P.

J Am Coll Cardiol. 2019 Oct 22;74(16):2115-2116. doi: 10.1016/j.jacc.2019.08.999. No abstract available.

PMID:
31623770
7.

Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort.

Peikert A, Kaier K, Merz J, Manhart L, Schäfer I, Hilgendorf I, Hehn P, Wolf D, Willecke F, Sheng X, Clemens A, Zehender M, von Zur Mühlen C, Bode C, Zirlik A, Stachon P.

Clin Res Cardiol. 2019 Jul 19. doi: 10.1007/s00392-019-01511-0. [Epub ahead of print]

PMID:
31325043
8.

Real-time magnetic resonance imaging - guided coronary intervention in a porcine model.

Heidt T, Reiss S, Krafft AJ, Özen AC, Lottner T, Hehrlein C, Galmbacher R, Kayser G, Hilgendorf I, Stachon P, Wolf D, Zirlik A, Düring K, Zehender M, Meckel S, von Elverfeldt D, Bode C, Bock M, von Zur Mühlen C.

Sci Rep. 2019 Jun 17;9(1):8663. doi: 10.1038/s41598-019-45154-7. Erratum in: Sci Rep. 2019 Nov 29;9(1):18282.

9.

Impaired SIRT3 activity mediates cardiac dysfunction in endotoxemia by calpain-dependent disruption of ATP synthesis.

Koentges C, Cimolai MC, Pfeil K, Wolf D, Marchini T, Tarkhnishvili A, Hoffmann MM, Odening KE, Diehl P, von Zur Mühlen C, Alvarez S, Bode C, Zirlik A, Bugger H.

J Mol Cell Cardiol. 2019 Aug;133:138-147. doi: 10.1016/j.yjmcc.2019.06.008. Epub 2019 Jun 13.

PMID:
31201798
10.

Nationwide outcomes of aortic valve replacement for pure aortic regurgitation in Germany 2008-2015.

Stachon P, Kaier K, Heidt T, Bothe W, Zirlik A, Zehender M, Bode C, von Zur Mühlen C.

Catheter Cardiovasc Interv. 2019 Jun 4. doi: 10.1002/ccd.28361. [Epub ahead of print]

PMID:
31165569
11.

Risk-Adjusted Comparison of In-Hospital Outcomes of Transcatheter and Surgical Aortic Valve Replacement.

Stachon P, Kaier K, Zirlik A, Bothe W, Heidt T, Zehender M, Bode C, von Zur Mühlen C.

J Am Heart Assoc. 2019 Apr 2;8(7):e011504. doi: 10.1161/JAHA.118.011504.

12.

The Optimal Anti-Thrombotic Regimen after Surgical Bioprosthetic Aortic Valve Replacement-Does it Really Matter?

von Zur Mühlen C, Bothe W, Bode C.

Thromb Haemost. 2019 Feb;119(2):189-190. doi: 10.1055/s-0038-1677504. Epub 2019 Jan 8.

PMID:
30620992
13.

Zn-alloy provides a novel platform for mechanically stable bioresorbable vascular stents.

Hehrlein C, Schorch B, Kress N, Arab A, von Zur Mühlen C, Bode C, Epting T, Haberstroh J, Mey L, Schwarzbach H, Kinscherf R, Stachniss V, Schiestel S, Kovacs A, Fischer H, Nennig E.

PLoS One. 2019 Jan 2;14(1):e0209111. doi: 10.1371/journal.pone.0209111. eCollection 2019.

14.

Estimating the additional costs per life saved due to transcatheter aortic valve replacement: a secondary data analysis of electronic health records in Germany.

Kaier K, von Zur Mühlen C, Zirlik A, Bothe W, Hehn P, Zehender M, Bode C, Stachon P.

Eur J Health Econ. 2019 Jun;20(4):625-632. doi: 10.1007/s10198-018-1023-x. Epub 2019 Jan 2.

PMID:
30600467
15.

[Development and Results of Transcatheter and Surgical Aortic Valve Replacement in Germany 2014 and 2015].

Stachon P, Kaier K, Zirlik A, Bothe W, Zehender M, Bode C, von Zur Mühlen C.

Dtsch Med Wochenschr. 2018 Nov;143(23):e206-e212. doi: 10.1055/a-0655-6218. Epub 2018 Nov 15. German.

PMID:
30440067
16.

Purinergic receptor Y2 (P2Y2)- dependent VCAM-1 expression promotes immune cell infiltration in metabolic syndrome.

Merz J, Albrecht P, von Garlen S, Ahmed I, Dimanski D, Wolf D, Hilgendorf I, Härdtner C, Grotius K, Willecke F, Heidt T, Bugger H, Hoppe N, Kintscher U, von Zur Mühlen C, Idzko M, Bode C, Zirlik A, Stachon P.

Basic Res Cardiol. 2018 Oct 18;113(6):45. doi: 10.1007/s00395-018-0702-1.

PMID:
30338362
17.

Sex-Specific Differences in Outcome of Transcatheter or Surgical Aortic Valve Replacement.

Kaier K, von Zur Mühlen C, Zirlik A, Schmoor C, Roth K, Bothe W, Hehn P, Reinöhl J, Zehender M, Bode C, Stachon P.

Can J Cardiol. 2018 Aug;34(8):992-998. doi: 10.1016/j.cjca.2018.04.009. Epub 2018 Apr 12.

PMID:
30056851
18.

Volume-outcome relationship in transcatheter aortic valve implantations in Germany 2008-2014: a secondary data analysis of electronic health records.

Kaier K, Oettinger V, Reinecke H, Schmoor C, Frankenstein L, Vach W, Hehn P, von Zur Mühlen C, Bode C, Zehender M, Reinöhl J.

BMJ Open. 2018 Jul 28;8(7):e020204. doi: 10.1136/bmjopen-2017-020204.

19.

Development and In-Hospital Mortality of Transcatheter and Surgical Aortic Valve Replacement in 2015 in Germany.

Stachon P, Zehender M, Bode C, von Zur Mühlen C, Kaier K.

J Am Coll Cardiol. 2018 Jul 24;72(4):475-476. doi: 10.1016/j.jacc.2018.04.077. No abstract available.

20.

Risk factors and outcome of postoperative delirium after transcatheter aortic valve replacement.

Stachon P, Kaier K, Zirlik A, Reinöhl J, Heidt T, Bothe W, Hehn P, Zehender M, Bode C, von Zur Mühlen C.

Clin Res Cardiol. 2018 Sep;107(9):756-762. doi: 10.1007/s00392-018-1241-3. Epub 2018 Apr 13.

PMID:
29654435
21.

A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense.

Wolf D, Anto-Michel N, Blankenbach H, Wiedemann A, Buscher K, Hohmann JD, Lim B, Bäuml M, Marki A, Mauler M, Duerschmied D, Fan Z, Winkels H, Sidler D, Diehl P, Zajonc DM, Hilgendorf I, Stachon P, Marchini T, Willecke F, Schell M, Sommer B, von Zur Muhlen C, Reinöhl J, Gerhardt T, Plow EF, Yakubenko V, Libby P, Bode C, Ley K, Peter K, Zirlik A.

Nat Commun. 2018 Feb 6;9(1):525. doi: 10.1038/s41467-018-02896-8.

22.

Coronary magnetic resonance imaging after routine implantation of bioresorbable vascular scaffolds allows non-invasive evaluation of vascular patency.

von Zur Mühlen C, Reiss S, Krafft AJ, Besch L, Menza M, Zehender M, Heidt T, Maier A, Pfannebecker T, Zirlik A, Reinöhl J, Stachon P, Hilgendorf I, Wolf D, Diehl P, Wengenmayer T, Ahrens I, Bode C, Bock M.

PLoS One. 2018 Jan 25;13(1):e0191413. doi: 10.1371/journal.pone.0191413. eCollection 2018.

23.

Inflammatory Pathways Regulated by Tumor Necrosis Receptor-Associated Factor 1 Protect From Metabolic Consequences in Diet-Induced Obesity.

Anto Michel N, Colberg C, Buscher K, Sommer B, Pramod AB, Ehinger E, Dufner B, Hoppe N, Pfeiffer K, Marchini T, Willecke F, Stachon P, Hilgendorf I, Heidt T, von Zur Muhlen C, von Elverfeldt D, Pfeifer D, Schüle R, Kintscher U, Brachs S, Ley K, Bode C, Zirlik A, Wolf D.

Circ Res. 2018 Mar 2;122(5):693-700. doi: 10.1161/CIRCRESAHA.117.312055. Epub 2018 Jan 22.

24.

A molecular intravascular ultrasound contrast agent allows detection of activated platelets on the surface of symptomatic human plaques.

Maier A, Plaza-Heck P, Meixner F, Guenther F, Kaufmann BA, Kramer M, Heidt T, Zirlik A, Hilgendorf I, Reinöhl J, Stachon P, Bronsert P, Birkemeyer R, Neudorfer I, Peter K, Bode C, von Zur Mühlen C.

Atherosclerosis. 2017 Dec;267:68-77. doi: 10.1016/j.atherosclerosis.2017.10.029. Epub 2017 Oct 24.

PMID:
29101838
25.

Two-year post-discharge costs of care among patients treated with transcatheter or surgical aortic valve replacement in Germany.

Kaier K, von Kampen F, Baumbach H, von Zur Mühlen C, Hehn P, Vach W, Zehender M, Bode C, Reinöhl J.

BMC Health Serv Res. 2017 Jul 11;17(1):473. doi: 10.1186/s12913-017-2432-8.

26.

Impact of pulmonary hypertension on in-hospital outcome after surgical or transcatheter aortic valve replacement.

Gutmann A, Kaier K, Reinecke H, Frankenstein L, Zirlik A, Bothe W, von Zur Mühlen C, Zehender M, Reinöhl J, Bode C, Stachon P.

EuroIntervention. 2017 Sep 20;13(7):804-810. doi: 10.4244/EIJ-D-16-00927.

27.

P2X7 Deficiency Blocks Lesional Inflammasome Activity and Ameliorates Atherosclerosis in Mice.

Stachon P, Heidenreich A, Merz J, Hilgendorf I, Wolf D, Willecke F, von Garlen S, Albrecht P, Härdtner C, Ehrat N, Hoppe N, Reinöhl J, von Zur Mühlen C, Bode C, Idzko M, Zirlik A.

Circulation. 2017 Jun 20;135(25):2524-2533. doi: 10.1161/CIRCULATIONAHA.117.027400. Epub 2017 Apr 4.

PMID:
28377486
28.

Prediction of acute coronary syndromes by urinary proteome analysis.

Htun NM, Magliano DJ, Zhang ZY, Lyons J, Petit T, Nkuipou-Kenfack E, Ramirez-Torres A, von Zur Muhlen C, Maahs D, Schanstra JP, Pontillo C, Pejchinovski M, Snell-Bergeon JK, Delles C, Mischak H, Staessen JA, Shaw JE, Koeck T, Peter K.

PLoS One. 2017 Mar 8;12(3):e0172036. doi: 10.1371/journal.pone.0172036. eCollection 2017.

29.

Inflammation, but not recruitment, of adipose tissue macrophages requires signalling through Mac-1 (CD11b/CD18) in diet-induced obesity (DIO).

Wolf D, Bukosza N, Engel D, Poggi M, Jehle F, Anto Michel N, Chen YC, Colberg C, Hoppe N, Dufner B, Boon L, Blankenbach H, Hilgendorf I, von Zur Muhlen C, Reinöhl J, Sommer B, Marchini T, Febbraio MA, Weber C, Bode C, Peter K, Lutgens E, Zirlik A.

Thromb Haemost. 2017 Jan 26;117(2):325-338. doi: 10.1160/TH16-07-0553. Epub 2016 Nov 17.

PMID:
27853810
30.

Transcatheter Aortic Valve Replacement: The New Standard in Patients With Previous Coronary Bypass Grafting?

Reinöhl J, Kaier K, Reinecke H, Frankenstein L, Zirlik A, Zehender M, von Zur Mühlen C, Bode C, Stachon P.

JACC Cardiovasc Interv. 2016 Oct 24;9(20):2137-2143. doi: 10.1016/j.jcin.2016.07.035.

31.

Quality of life among elderly patients undergoing transcatheter or surgical aortic valve replacement- a model-based longitudinal data analysis.

Kaier K, Gutmann A, Baumbach H, von Zur Mühlen C, Hehn P, Vach W, Beyersdorf F, Zehender M, Bode C, Reinöhl J.

Health Qual Life Outcomes. 2016 Jul 26;14(1):109. doi: 10.1186/s12955-016-0512-9.

32.

Extracellular ATP Induces Vascular Inflammation and Atherosclerosis via Purinergic Receptor Y2 in Mice.

Stachon P, Geis S, Peikert A, Heidenreich A, Michel NA, Ünal F, Hoppe N, Dufner B, Schulte L, Marchini T, Cicko S, Ayata K, Zech A, Wolf D, Hilgendorf I, Willecke F, Reinöhl J, von Zur Mühlen C, Bode C, Idzko M, Zirlik A.

Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1577-86. doi: 10.1161/ATVBAHA.115.307397. Epub 2016 Jun 23.

PMID:
27339459
33.

Age dependence of pulmonary artery blood flow measured by 4D flow cardiovascular magnetic resonance: results of a population-based study.

Wehrum T, Hagenlocher P, Lodemann T, Vach W, Dragonu I, Hennemuth A, von Zur Mühlen C, Stuplich J, Ngo BT, Harloff A.

J Cardiovasc Magn Reson. 2016 May 31;18(1):31. doi: 10.1186/s12968-016-0252-3.

34.

Acute exposure to air pollution particulate matter aggravates experimental myocardial infarction in mice by potentiating cytokine secretion from lung macrophages.

Marchini T, Wolf D, Michel NA, Mauler M, Dufner B, Hoppe N, Beckert J, Jäckel M, Magnani N, Duerschmied D, Tasat D, Alvarez S, Reinöhl J, von Zur Muhlen C, Idzko M, Bode C, Hilgendorf I, Evelson P, Zirlik A.

Basic Res Cardiol. 2016 Jul;111(4):44. doi: 10.1007/s00395-016-0562-5. Epub 2016 May 30.

35.

Molecular Imaging of Activated Platelets Allows the Detection of Pulmonary Embolism with Magnetic Resonance Imaging.

Heidt T, Ehrismann S, Hövener JB, Neudorfer I, Hilgendorf I, Reisert M, Hagemeyer CE, Zirlik A, Reinöhl J, Bode C, Peter K, von Elverfeldt D, von Zur Muhlen C.

Sci Rep. 2016 May 3;6:25044. doi: 10.1038/srep25044.

36.

Urine proteome analysis as a discovery tool in patients with deep vein thrombosis and pulmonary embolism.

von Zur Mühlen C, Koeck T, Schiffer E, Sackmann C, Zürbig P, Hilgendorf I, Reinöhl J, Rivera J, Zirlik A, Hehrlein C, Mischak H, Bode C, Peter K.

Proteomics Clin Appl. 2016 May;10(5):574-84. doi: 10.1002/prca.201500105. Epub 2016 Apr 4.

PMID:
26898369
37.

Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression.

Lindau A, Härdtner C, Hergeth SP, Blanz KD, Dufner B, Hoppe N, Anto-Michel N, Kornemann J, Zou J, Gerhardt LM, Heidt T, Willecke F, Geis S, Stachon P, Wolf D, Libby P, Swirski FK, Robbins CS, McPheat W, Hawley S, Braddock M, Gilsbach R, Hein L, von zur Mühlen C, Bode C, Zirlik A, Hilgendorf I.

Basic Res Cardiol. 2016 Mar;111(2):20. doi: 10.1007/s00395-016-0535-8. Epub 2016 Feb 18.

38.

Aortic root volume is associated with contained rupture of the aortic annulus in balloon-expandable transcatheter aortic valve replacement.

Reinöhl J, Psyrakis D, Kaier K, Kodirov S, Siepe M, Gutmann A, von zur Mühlen C, Moser M, Ahrens I, Pache G, Zirlik A, Langer M, Beyersdorf F, Zehender M, Bode C, Blanke P.

Catheter Cardiovasc Interv. 2016 Mar;87(4):807-17. doi: 10.1002/ccd.26260. Epub 2015 Oct 26.

PMID:
26501403
39.

In-hospital resource utilization in surgical and transcatheter aortic valve replacement.

Reinöhl J, Kaier K, Gutmann A, Sorg S, von Zur Mühlen C, Siepe M, Baumbach H, Moser M, Geibel A, Zirlik A, Blanke P, Vach W, Beyersdorf F, Bode C, Zehender M.

BMC Cardiovasc Disord. 2015 Oct 22;15:132. doi: 10.1186/s12872-015-0118-x.

40.

Preprocedural planning and implantation of a transcatheter aortic valve without the use of contrast agent.

Reinöhl J, Pache G, Ahrens I, Heidt T, Psyrakis D, Latib A, De Marco F, Schröfel H, Beyersdorf F, Zehender M, Bode C, von Zur Mühlen C.

EuroIntervention. 2016 Mar;11(12):1433. doi: 10.4244/EIJY15M07_06. No abstract available.

41.

Immuno-magnetoliposomes targeting activated platelets as a potentially human-compatible MRI contrast agent for targeting atherothrombosis.

Meier S, Pütz G, Massing U, Hagemeyer CE, von Elverfeldt D, Meissner M, Ardipradja K, Barnert S, Peter K, Bode C, Schubert R, von zur Muhlen C.

Biomaterials. 2015 Jun;53:137-48. doi: 10.1016/j.biomaterials.2015.02.088. Epub 2015 Mar 12.

PMID:
25890714
42.

Magnetic resonance imaging of bioresorbable vascular scaffolds: potential approach for noninvasive evaluation of coronary patency.

Reiss S, Krafft AJ, Zehender M, Heidt T, Pfannebecker T, Bode C, Bock M, von Zur Muhlen C.

Circ Cardiovasc Interv. 2015 Apr;8(4). pii: e002388. doi: 10.1161/CIRCINTERVENTIONS.115.002388. No abstract available.

PMID:
25794509
43.

Two-year survival of patients screened for transcatheter aortic valve replacement with potentially malignant incidental findings in initial body computed tomography.

Stachon P, Kaier K, Milde S, Pache G, Sorg S, Siepe M, von zur Mühlen C, Zirlik A, Beyersdorf F, Langer M, Zehender M, Bode C, Reinöhl J.

Eur Heart J Cardiovasc Imaging. 2015 Jul;16(7):731-7. doi: 10.1093/ehjci/jev055. Epub 2015 Mar 10.

44.

MRI, the technology for imaging of thrombi and inflammation.

von Zur Muhlen C, Bode C.

Hamostaseologie. 2015;35(3):252-62. doi: 10.5482/HAMO-14-11-0061. Epub 2015 Jan 30. Review.

PMID:
25634650
45.

"Heart Team" decision making in elderly patients with symptomatic aortic valve stenosis who underwent AVR or TAVI - a look behind the curtain. Results of the prospective TAVI Calculation of Costs Trial (TCCT).

Kaier K, Gutmann A, Vach W, Sorg S, Siepe M, von Zur Mühlen C, Moser M, Blanke P, Beyersdorf F, Zehender M, Bode C, Reinöhl J.

EuroIntervention. 2015 Nov;11(7):793-8. doi: 10.4244/EIJY14M12_06.

46.

Analysis of the additional costs of clinical complications in patients undergoing transcatheter aortic valve replacement in the German Health Care System.

Gutmann A, Kaier K, Sorg S, von Zur Mühlen C, Siepe M, Moser M, Geibel A, Zirlik A, Ahrens I, Baumbach H, Beyersdorf F, Vach W, Zehender M, Bode C, Reinöhl J.

Int J Cardiol. 2015 Jan 20;179:231-7. doi: 10.1016/j.ijcard.2014.11.095. Epub 2014 Nov 11.

PMID:
25464455
47.

P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.

Stachon P, Peikert A, Michel NA, Hergeth S, Marchini T, Wolf D, Dufner B, Hoppe N, Ayata CK, Grimm M, Cicko S, Schulte L, Reinöhl J, von zur Muhlen C, Bode C, Idzko M, Zirlik A.

Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2237-45. doi: 10.1161/ATVBAHA.114.303585. Epub 2014 Aug 7.

PMID:
25104800
48.

Chronic variable stress activates hematopoietic stem cells.

Heidt T, Sager HB, Courties G, Dutta P, Iwamoto Y, Zaltsman A, von Zur Muhlen C, Bode C, Fricchione GL, Denninger J, Lin CP, Vinegoni C, Libby P, Swirski FK, Weissleder R, Nahrendorf M.

Nat Med. 2014 Jul;20(7):754-758. doi: 10.1038/nm.3589. Epub 2014 Jun 22.

49.

Dual-contrast molecular imaging allows noninvasive characterization of myocardial ischemia/reperfusion injury after coronary vessel occlusion in mice by magnetic resonance imaging.

von Elverfeldt D, Maier A, Duerschmied D, Braig M, Witsch T, Wang X, Mauler M, Neudorfer I, Menza M, Idzko M, Zirlik A, Heidt T, Bronsert P, Bode C, Peter K, von Zur Muhlen C.

Circulation. 2014 Aug 19;130(8):676-87. doi: 10.1161/CIRCULATIONAHA.113.008157. Epub 2014 Jun 20.

PMID:
24951772
50.

Coinhibitory suppression of T cell activation by CD40 protects against obesity and adipose tissue inflammation in mice.

Wolf D, Jehle F, Michel NA, Bukosza EN, Rivera J, Chen YC, Hoppe N, Dufner B, Rodriguez AO, Colberg C, Nieto L, Rupprecht B, Wiedemann A, Schulte L, Peikert A, Bassler N, Lozhkin A, Hergeth SP, Stachon P, Hilgendorf I, Willecke F, von Zur Mühlen C, von Elverfeldt D, Binder CJ, Aichele P, Varo N, Febbraio MA, Libby P, Bode C, Peter K, Zirlik A.

Circulation. 2014 Jun 10;129(23):2414-25. doi: 10.1161/CIRCULATIONAHA.113.008055. Epub 2014 Mar 24.

PMID:
24664276

Supplemental Content

Loading ...
Support Center